Elbeik T - Search Results

1

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy.

Deeks SG, Hecht FM, Swanson M, Elbeik T, Loftus R, Cohen PT, Grant RM. Deeks SG, et al. Among authors: elbeik t. AIDS. 1999 Apr 16;13(6):F35-43. doi: 10.1097/00002030-199904160-00001. AIDS. 1999. PMID: 10397555

2

Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccination.

Locher CP, Grant RM, Collisson EA, Reyes-Terán G, Elbeik T, Kahn JO, Levy JA. Locher CP, et al. Among authors: elbeik t. AIDS Res Hum Retroviruses. 1999 Dec 10;15(18):1685-9. doi: 10.1089/088922299309720. AIDS Res Hum Retroviruses. 1999. PMID: 10606091

3

Activation of virus replication after vaccination of HIV-1-infected individuals.

Staprans SI, Hamilton BL, Follansbee SE, Elbeik T, Barbosa P, Grant RM, Feinberg MB. Staprans SI, et al. Among authors: elbeik t. J Exp Med. 1995 Dec 1;182(6):1727-37. doi: 10.1084/jem.182.6.1727. J Exp Med. 1995. PMID: 7500017 Free PMC article. Clinical Trial.

4

Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial.

Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, Benowitz NL, Bredt BM, Kosel B, Aberg JA, Deeks SG, Mitchell TF, Mulligan K, Bacchetti P, McCune JM, Schambelan M. Abrams DI, et al. Among authors: elbeik ta. Ann Intern Med. 2003 Aug 19;139(4):258-66. doi: 10.7326/0003-4819-139-4-200308190-00008. Ann Intern Med. 2003. PMID: 12965981 Clinical Trial.

5

Health care industries' perspective of viral load assays: the VERSANT HIV-1 RNA 3.0 assay.

Elbeik T, Loftus RA, Beringer S. Elbeik T, et al. Expert Rev Mol Diagn. 2002 May;2(3):275-85. doi: 10.1586/14737159.2.3.275. Expert Rev Mol Diagn. 2002. PMID: 12050866

6

Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5.

Elbeik T, Charlebois E, Nassos P, Kahn J, Hecht FM, Yajko D, Ng V, Hadley K. Elbeik T, et al. J Clin Microbiol. 2000 Mar;38(3):1113-20. doi: 10.1128/JCM.38.3.1113-1120.2000. J Clin Microbiol. 2000. PMID: 10699005 Free PMC article.

7

Cost assessment of the automated VERSANT 440 Molecular System versus the semi-automated System 340 bDNA Analyzer platforms.

Elbeik T, Loftus RA, Beringer S. Elbeik T, et al. Expert Rev Mol Diagn. 2007 Nov;7(6):713-22. doi: 10.1586/14737159.7.6.713. Expert Rev Mol Diagn. 2007. PMID: 18020902

8

HIV-1 and HCV viral load cost models for bDNA: 440 Molecular System versus real-time PCR AmpliPrep/TaqMan test.

Elbeik T, Dalessandro R, Loftus RA, Beringer S. Elbeik T, et al. Expert Rev Mol Diagn. 2007 Nov;7(6):723-53. doi: 10.1586/14737159.7.6.723. Expert Rev Mol Diagn. 2007. PMID: 18020903

9

Global cost modeling analysis of HIV-1 and HCV viral load assays.

Elbeik T, Chen YM, Soutchkov SV, Loftus RA, Beringer S. Elbeik T, et al. Expert Rev Pharmacoecon Outcomes Res. 2003 Aug;3(4):383-407. doi: 10.1586/14737167.3.4.383. Expert Rev Pharmacoecon Outcomes Res. 2003. PMID: 19807450

10

Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team.

Hughes MD, Johnson VA, Hirsch MS, Bremer JW, Elbeik T, Erice A, Kuritzkes DR, Scott WA, Spector SA, Basgoz N, Fischl MA, D'Aquila RT. Hughes MD, et al. Among authors: elbeik t. Ann Intern Med. 1997 Jun 15;126(12):929-38. doi: 10.7326/0003-4819-126-12-199706150-00001. Ann Intern Med. 1997. PMID: 9182469 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters